We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an e... Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage. Show more
Spyre Therapeutics Announces Grants of Inducement Awards PR Newswire WALTHAM, Mass., May 3, 2024 WALTHAM, Mass., May 3, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company...
Spyre Therapeutics Announces Grants of Inducement Awards PR Newswire WALTHAM, Mass., April 1, 2024 WALTHAM, Mass., April 1, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the...
Spyre Therapeutics Announces $180 Million Private Placement PR Newswire WALTHAM, Mass., March 18, 2024 WALTHAM, Mass., March 18, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. ("Spyre" or the...
Spyre Therapeutics Announces Grants of Inducement Awards PR Newswire WALTHAM, Mass., March 1, 2024 WALTHAM, Mass., March 1, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.53 | -1.517320355 | 34.93 | 39.04 | 31.385 | 390973 | 34.53265464 | CS |
| 4 | -3.04 | -8.11965811966 | 37.44 | 40.835 | 31.27 | 322317 | 35.14512533 | CS |
| 12 | 12.06 | 53.9838854073 | 22.34 | 47.97 | 20.07 | 509305 | 34.56502732 | CS |
| 26 | 23.59 | 218.22386679 | 10.81 | 47.97 | 10.42 | 383509 | 30.98171765 | CS |
| 52 | 23.59 | 218.22386679 | 10.81 | 47.97 | 10.42 | 383509 | 30.98171765 | CS |
| 156 | 23.59 | 218.22386679 | 10.81 | 47.97 | 10.42 | 383509 | 30.98171765 | CS |
| 260 | 23.59 | 218.22386679 | 10.81 | 47.97 | 10.42 | 383509 | 30.98171765 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
